Black Rock Inc. Eagle Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 897,806 shares of EGRX stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

897,806

Previous 984,908 8.84%

Holding current value

$4.09 Million

Previous $5.15 Million 8.68%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.26 - $6.51 $371,054 - $567,034	-87,102 Reduced 8.84%	897,806 $4.7 Million
Q4 2023 Feb 13, 2024	BUY	$4.63 - $15.21 $443,688 - $1.46 Million	95,829 Added 10.78%	984,908 $5.15 Million
Q3 2023 Nov 13, 2023	SELL	$15.21 - $22.88 $1.85 Million - $2.78 Million	-121,558 Reduced 12.03%	889,079 $14 Million
Q2 2023 Aug 11, 2023	SELL	$17.74 - $31.87 $15.4 Million - $27.6 Million	-865,462 Reduced 46.13%	1,010,637 $19.6 Million
Q1 2023 May 12, 2023	BUY	$25.06 - $34.09 $41,374 - $56,282	1,651 Added 0.09%	1,876,099 $53.2 Million

Q4 2022 Feb 13, 2023	BUY	$24.98 - $39.77 $287,644 - $457,951	11,515 Added 0.62%	1,874,448 $54.8 Million
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $1.97 Million - $3.51 Million	-74,431 Reduced 3.84%	1,862,933 $49.2 Million
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $1.86 Million - $2.31 Million	-44,969 Reduced 2.27%	1,937,364 $86.1 Million
Q1 2022 May 12, 2022	BUY	$44.58 - $52.6 $602,587 - $710,994	13,517 Added 0.69%	1,982,333 $98.1 Million
Q4 2021 Feb 10, 2022	SELL	$45.82 - $56.9 $3.55 Million - $4.41 Million	-77,470 Reduced 3.79%	1,968,816 $100 Million
Q3 2021 Nov 09, 2021	SELL	$43.79 - $55.78 $1.57 Million - $2 Million	-35,897 Reduced 1.72%	2,046,286 $114 Million
Q2 2021 Aug 11, 2021	BUY	$36.86 - $44.5 $76.7 Million - $92.7 Million	2,082,183 New	2,082,183 $89.1 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

10.4M

Call Options Held

Put Options Held

36.3K

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $59.2M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account